Skip to main content
Erschienen in: Japanese Journal of Radiology 3/2018

26.12.2017 | Original Article

Examining alterations in GABA concentrations in the basal ganglia of patients with Parkinson’s disease using MEGA-PRESS MRS

verfasst von: Elsadig E. A. Elmaki, Tao Gong, D. Menene Nkonika, Guangbin Wang

Erschienen in: Japanese Journal of Radiology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to compare the gamma-amino butyric acid (GABA) levels in the left basal ganglia (BG) of patients with Parkinson’s disease (PD) to those of healthy control (HC) volunteers using proton magnetic resonance spectroscopy (1H MRS).

Materials and methods

The GABA+ signal—the composite signal from GABA, macromolecules (MMs), and homocarnosine—was detected. GABA+ levels were examined in 21 PD patients and 15 age- and sex-matched HCs. 3T-1H-MRS using the Mescher–Garwood point-resolved spectroscopy (MEGA-PRESS) sequence was performed in order to detect GABA+ levels in the left BG, and the spectra were processed using the Gannet software. Differences in GABA+ levels between the two groups were analyzed using independent t-test analysis.

Results

The GABA+ levels were significantly lower (P < 0.001) in the left BG of the patients with PD (1.31 ± 0.21 i.u.) than in the left BG of the HCs (1.62 ± 0.26 i.u.).

Conclusion

The lower GABA+ levels in the left BG of the PD patients suggest that GABA plays an important role in the pathogenesis of PD. The reduced GABA+ levels in the PD patients may be associated with GABAergic dysfunction.
Literatur
1.
Zurück zum Zitat Emir UE, Tuite PJ, Oz G. Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS. PLoS One. 2012;7(1):e30918.CrossRefPubMedPubMedCentral Emir UE, Tuite PJ, Oz G. Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS. PLoS One. 2012;7(1):e30918.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Ciurleo R, Di Lorenzo G, Bramanti P, Marino S. Magnetic resonance spectroscopy: an in vivo molecular imaging biomarker for Parkinson’s disease? Biomed Res Int. 2014;2014:519816.CrossRefPubMedPubMedCentral Ciurleo R, Di Lorenzo G, Bramanti P, Marino S. Magnetic resonance spectroscopy: an in vivo molecular imaging biomarker for Parkinson’s disease? Biomed Res Int. 2014;2014:519816.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Tremblay L, Worbe Y, Thobois S, Sgambato-Faure V, Feger J. Selective dysfunction of basal ganglia subterritories: from movement to behavioral disorders. Mov Disord Off J Mov Disord Soc. 2015;30(9):1155–70.CrossRef Tremblay L, Worbe Y, Thobois S, Sgambato-Faure V, Feger J. Selective dysfunction of basal ganglia subterritories: from movement to behavioral disorders. Mov Disord Off J Mov Disord Soc. 2015;30(9):1155–70.CrossRef
4.
Zurück zum Zitat Oz G, Terpstra M, Tkac I, Aia P, Lowary J, Tuite PJ, et al. Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations. Magn Reson Med. 2006;55(2):296–301.CrossRefPubMed Oz G, Terpstra M, Tkac I, Aia P, Lowary J, Tuite PJ, et al. Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations. Magn Reson Med. 2006;55(2):296–301.CrossRefPubMed
5.
Zurück zum Zitat Wabnegger A, Ille R, Schwingenschuh P, Katschnig-Winter P, Kogl-Wallner M, Wenzel K, et al. Facial emotion recognition in Parkinson’s disease: an fMRI investigation. PLoS One. 2015;10(8):e0136110.CrossRefPubMedPubMedCentral Wabnegger A, Ille R, Schwingenschuh P, Katschnig-Winter P, Kogl-Wallner M, Wenzel K, et al. Facial emotion recognition in Parkinson’s disease: an fMRI investigation. PLoS One. 2015;10(8):e0136110.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Ding S, Li L, Zhou FM. Nigral dopamine loss induces a global upregulation of presynaptic dopamine D1 receptor facilitation of the striatonigral GABAergic output. J Neurophysiol. 2015;113(6):1697–711.CrossRefPubMed Ding S, Li L, Zhou FM. Nigral dopamine loss induces a global upregulation of presynaptic dopamine D1 receptor facilitation of the striatonigral GABAergic output. J Neurophysiol. 2015;113(6):1697–711.CrossRefPubMed
7.
Zurück zum Zitat Gao HC, Zhu H, Song CY, Lin L, Xiang Y, Yan ZH, et al. Metabolic changes detected by ex vivo high resolution 1H NMR spectroscopy in the striatum of 6-OHDA-induced Parkinson’s rat. Mol Neurobiol. 2013;47(1):123–30.CrossRefPubMed Gao HC, Zhu H, Song CY, Lin L, Xiang Y, Yan ZH, et al. Metabolic changes detected by ex vivo high resolution 1H NMR spectroscopy in the striatum of 6-OHDA-induced Parkinson’s rat. Mol Neurobiol. 2013;47(1):123–30.CrossRefPubMed
8.
Zurück zum Zitat Mullins PG, McGonigle DJ, O’Gorman RL, Puts NA, Vidyasagar R, Evans CJ, et al. Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA. Neuroimage. 2014;86:43–52.CrossRefPubMed Mullins PG, McGonigle DJ, O’Gorman RL, Puts NA, Vidyasagar R, Evans CJ, et al. Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA. Neuroimage. 2014;86:43–52.CrossRefPubMed
9.
Zurück zum Zitat Harris AD, Puts NA, Barker PB, Edden RA. Spectral-editing measurements of GABA in the human brain with and without macromolecule suppression. Magn Reson Med. 2015;74(6):1523–9.CrossRefPubMed Harris AD, Puts NA, Barker PB, Edden RA. Spectral-editing measurements of GABA in the human brain with and without macromolecule suppression. Magn Reson Med. 2015;74(6):1523–9.CrossRefPubMed
10.
Zurück zum Zitat Bai X, Edden RA, Gao F, Wang G, Wu L, Zhao B, et al. Decreased gamma-aminobutyric acid levels in the parietal region of patients with Alzheimer’s disease. J Magn Reson Imaging JMRI. 2015;41(5):1326–31.CrossRefPubMed Bai X, Edden RA, Gao F, Wang G, Wu L, Zhao B, et al. Decreased gamma-aminobutyric acid levels in the parietal region of patients with Alzheimer’s disease. J Magn Reson Imaging JMRI. 2015;41(5):1326–31.CrossRefPubMed
11.
Zurück zum Zitat Liu B, Wang G, Gao D, Gao F, Zhao B, Qiao M, et al. Alterations of GABA and glutamate-glutamine levels in premenstrual dysphoric disorder: a 3T proton magnetic resonance spectroscopy study. Psychiatry Res. 2015;231(1):64–70.CrossRefPubMed Liu B, Wang G, Gao D, Gao F, Zhao B, Qiao M, et al. Alterations of GABA and glutamate-glutamine levels in premenstrual dysphoric disorder: a 3T proton magnetic resonance spectroscopy study. Psychiatry Res. 2015;231(1):64–70.CrossRefPubMed
12.
Zurück zum Zitat Michou E, Williams S, Vidyasagar R, Downey D, Mistry S, Edden RA, et al. fMRI and MRS measures of neuroplasticity in the pharyngeal motor cortex. Neuroimage. 2015;117:1–10.CrossRefPubMedPubMedCentral Michou E, Williams S, Vidyasagar R, Downey D, Mistry S, Edden RA, et al. fMRI and MRS measures of neuroplasticity in the pharyngeal motor cortex. Neuroimage. 2015;117:1–10.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Edden RA, Puts NA, Harris AD, Barker PB, Evans CJ. Gannet: a batch-processing tool for the quantitative analysis of gamma-aminobutyric acid-edited MR spectroscopy spectra. J Magn Reson Imaging JMRI. 2014;40(6):1445–52.CrossRefPubMed Edden RA, Puts NA, Harris AD, Barker PB, Evans CJ. Gannet: a batch-processing tool for the quantitative analysis of gamma-aminobutyric acid-edited MR spectroscopy spectra. J Magn Reson Imaging JMRI. 2014;40(6):1445–52.CrossRefPubMed
14.
Zurück zum Zitat Myers JF, Evans CJ, Kalk NJ, Edden RA, Lingford-Hughes AR. Measurement of GABA using J-difference edited 1H-MRS following modulation of synaptic GABA concentration with tiagabine. Synapse. 2014;68(8):355–62.CrossRefPubMed Myers JF, Evans CJ, Kalk NJ, Edden RA, Lingford-Hughes AR. Measurement of GABA using J-difference edited 1H-MRS following modulation of synaptic GABA concentration with tiagabine. Synapse. 2014;68(8):355–62.CrossRefPubMed
15.
Zurück zum Zitat Coune PG, Craveiro M, Gaugler MN, Mlynarik V, Schneider BL, Aebischer P, et al. An in vivo ultrahigh field 14.1 T. (1) H-MRS study on 6-OHDA and alpha-synuclein-based rat models of Parkinson’s disease: GABA as an early disease marker. NMR Biomed. 2013;26(1):43–50.CrossRefPubMed Coune PG, Craveiro M, Gaugler MN, Mlynarik V, Schneider BL, Aebischer P, et al. An in vivo ultrahigh field 14.1 T. (1) H-MRS study on 6-OHDA and alpha-synuclein-based rat models of Parkinson’s disease: GABA as an early disease marker. NMR Biomed. 2013;26(1):43–50.CrossRefPubMed
16.
Zurück zum Zitat Mazuel L, Chassain C, Jean B, Pereira B, Cladiere A, Speziale C, et al. Proton MR spectroscopy for diagnosis and evaluation of treatment efficacy in Parkinson disease. Radiology. 2016;278(2):505–13. Mazuel L, Chassain C, Jean B, Pereira B, Cladiere A, Speziale C, et al. Proton MR spectroscopy for diagnosis and evaluation of treatment efficacy in Parkinson disease. Radiology. 2016;278(2):505–13.
17.
Zurück zum Zitat Lee KJ, Shim I, Sung JH, Hong JT, Kim IS, Cho CB. Striatal glutamate and GABA after high frequency subthalamic stimulation in parkinsonian rat. J Korean Neurosurg Soc. 2017;60(2):138–45.CrossRefPubMedPubMedCentral Lee KJ, Shim I, Sung JH, Hong JT, Kim IS, Cho CB. Striatal glutamate and GABA after high frequency subthalamic stimulation in parkinsonian rat. J Korean Neurosurg Soc. 2017;60(2):138–45.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Ham BJ, Sung Y, Kim N, Kim SJ, Kim JE, Kim DJ, et al. Decreased GABA levels in anterior cingulate and basal ganglia in medicated subjects with panic disorder: a proton magnetic resonance spectroscopy (1H-MRS) study. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(2):403–11.CrossRefPubMed Ham BJ, Sung Y, Kim N, Kim SJ, Kim JE, Kim DJ, et al. Decreased GABA levels in anterior cingulate and basal ganglia in medicated subjects with panic disorder: a proton magnetic resonance spectroscopy (1H-MRS) study. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(2):403–11.CrossRefPubMed
19.
Zurück zum Zitat Nieto-Gonzalez JL, Moser J, Lauritzen M, Schmitt-John T, Jensen K. Reduced GABAergic inhibition explains cortical hyperexcitability in the wobbler mouse model of ALS. Cereb Cortex. 2011;21(3):625–35.CrossRefPubMed Nieto-Gonzalez JL, Moser J, Lauritzen M, Schmitt-John T, Jensen K. Reduced GABAergic inhibition explains cortical hyperexcitability in the wobbler mouse model of ALS. Cereb Cortex. 2011;21(3):625–35.CrossRefPubMed
Metadaten
Titel
Examining alterations in GABA concentrations in the basal ganglia of patients with Parkinson’s disease using MEGA-PRESS MRS
verfasst von
Elsadig E. A. Elmaki
Tao Gong
D. Menene Nkonika
Guangbin Wang
Publikationsdatum
26.12.2017
Verlag
Springer Japan
Erschienen in
Japanese Journal of Radiology / Ausgabe 3/2018
Print ISSN: 1867-1071
Elektronische ISSN: 1867-108X
DOI
https://doi.org/10.1007/s11604-017-0714-z

Weitere Artikel der Ausgabe 3/2018

Japanese Journal of Radiology 3/2018 Zur Ausgabe

Acknowledgment

Acknowledgment

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.